APYX MEDICAL CORPORATION (APYX) Free cash flow 2016–2025
APYX MEDICAL CORPORATION (APYX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.1MFY2025 · since FY2016: -$3.1M → -$9.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.1M | +51.4% |
| FY2024 | -$18.8M | -224.6% |
| FY2023 | -$5.8M | +72.8% |
| FY2022 | -$21.3M | -90.6% |
| FY2021 | -$11.2M | +32.9% |
| FY2020 | -$16.6M | +15.8% |
| FY2019 | -$19.8M | +6.9% |
| FY2018 | -$21.2M | -390.9% |
| FY2017 | -$4.3M | -38.6% |
| FY2016 | -$3.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice